AbbVie
ABBV
ABBV
3,153 hedge funds and large institutions have $255B invested in AbbVie in 2022 Q4 according to their latest regulatory filings, with 362 funds opening new positions, 1,187 increasing their positions, 1,256 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,153
Holders Change
+197
Holders Change %
+6.66%
% of All Funds
50.87%
Holding in Top 10
346
Holding in Top 10 Change
+69
Holding in Top 10 Change %
+24.91%
% of All Funds
5.58%
New
362
Increased
1,187
Reduced
1,256
Closed
101
Calls
$2.99B
Puts
$3.13B
Net Calls
-$139M
Net Calls Change
-$411M
Top Buyers
| 1 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
$57B |
| 2 |
BlackRock
New York
|
$22.4B |
| 3 |
Morgan Stanley
New York
|
$5.1B |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$530M |
| 5 |
JPMorgan Chase & Co
New York
|
$9.84B |
